» Articles » PMID: 21403390

Microglia Demonstrate Age-dependent Interaction with Amyloid-β Fibrils

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2011 Mar 16
PMID 21403390
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is an age-associated disease characterized by increased accumulation of extracellular amyloid-β (Aβ) plaques within the brain. Histological examination has also revealed profound microglial activation in diseased brains often in association with these fibrillar peptide aggregates. The paradoxical presence of increased, reactive microglia yet accumulating extracellular debris suggests that these cells may be phagocytically compromised during disease. Prior work has demonstrated that primary microglia from adult mice are unable to phagocytose fibrillar Aβ1-42 in vitro when compared to microglia cultured from early postnatal animals. These data suggest that microglia undergo an age-associated decrease in microglial ability to interact with Aβ fibrils. In order to better define a temporal profile of microglia-Aβ interaction, acutely isolated, rather than cultured, microglia from 2 month, 6 month, and postnatal day 0 C57BL/6 mice were compared. Postnatal day 0 microglia demonstrated a CD47 dependent ability to phagocytose Aβ fibrils that was lost by 6 months. This corresponded with the ability of postnatal day 0 but not adult microglia to decrease Aβ immunoreactive plaque load from AD sections in vitro. In spite of limited Aβ uptake ability, adult microglia had functional phagocytic uptake of bacterial bioparticles and demonstrated the ability to adhere to both Aβ plaques and in vitro fibrillized Aβ. These data demonstrate a temporal profile of specifically Aβ-microglia interaction with a critical developmental period at 6 months in which cells remain able to interact with Aβ fibrils but lose their ability to phagocytose it.

Citing Articles

Immunofluorescence Staining of Murine Spinal Cord Sections to Evaluate Microglial Activation and Astrogliosis.

Amoriello R, Ballerini C Methods Mol Biol. 2024; 2857:159-167.

PMID: 39348064 DOI: 10.1007/978-1-0716-4128-6_15.


Cathepsin B modulates microglial migration and phagocytosis of amyloid β in Alzheimer's disease through PI3K-Akt signaling.

Jiang M, Zhao D, Zhou Y, Kong W, Xie Z, Xiong Y Neuropsychopharmacology. 2024; 50(4):640-650.

PMID: 39304744 PMC: 11845476. DOI: 10.1038/s41386-024-01994-0.


Sequence of Molecular Events in the Development of Alzheimer's Disease: Cascade Interactions from Beta-Amyloid to Other Involved Proteins.

Bagheri S, Saboury A, Saso L Cells. 2024; 13(15.

PMID: 39120323 PMC: 11312137. DOI: 10.3390/cells13151293.


Rejuvenating aged microglia by p16-siRNA-loaded nanoparticles increases amyloid-β clearance in animal models of Alzheimer's disease.

Shin H, Kim I, Choi S, Lee K, Park H, Shin J Mol Neurodegener. 2024; 19(1):25.

PMID: 38493185 PMC: 10943801. DOI: 10.1186/s13024-024-00715-x.


The role of CD47 in non-neoplastic diseases.

Wang C, Feng Y, Patel D, Xie H, Lv Y, Zhao H Heliyon. 2023; 9(12):e22905.

PMID: 38125492 PMC: 10731077. DOI: 10.1016/j.heliyon.2023.e22905.


References
1.
Westerman M, Mariash A, Kotilinek L, Kawarabayashi T, Younkin L, Carlson G . The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci. 2002; 22(5):1858-67. PMC: 6758862. View

2.
Koenigsknecht J, Landreth G . Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. J Neurosci. 2004; 24(44):9838-46. PMC: 6730228. DOI: 10.1523/JNEUROSCI.2557-04.2004. View

3.
Chung J, Gao A, Frazier W . Thrombspondin acts via integrin-associated protein to activate the platelet integrin alphaIIbbeta3. J Biol Chem. 1997; 272(23):14740-6. DOI: 10.1074/jbc.272.23.14740. View

4.
Van Nostrand W, Melchor J, Keane D, Romanov G, Davis J, Xu F . Localization of a fibrillar amyloid beta-protein binding domain on its precursor. J Biol Chem. 2002; 277(39):36392-8. DOI: 10.1074/jbc.M204676200. View

5.
Town T, Laouar Y, Pittenger C, Mori T, Szekely C, Tan J . Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat Med. 2008; 14(6):681-7. PMC: 2649699. DOI: 10.1038/nm1781. View